Abstract
Bipolar disorder (BD) is a genetically complex mental illness characterized by severe oscillations of mood and behaviour. Genome-wide association studies (GWAS) have identified several risk loci that together account for a small portion of the heritability. To identify additional risk loci, we performed a two-stage meta-analysis of > 9 million genetic variants in 9,784 bipolar disorder patients and 30,471 controls, the largest GWAS of BD to date. In this study, to increase power we used ~2,000 lithium-treated cases with a long-term diagnosis of BD from the Consortium on Lithium Genetics, excess controls, and analytic methods optimized for markers on the X-chromosome. In addition to four known loci, results revealed genome-wide significant associations at two novel loci: an intergenic region on 9p21.3 (rs12553324, P= 5.87×10-9; odds ratio (OR)=1.12) and markers within ERBB2 (rs2517959, P= 4.53×10-9; OR=1.13). No significant X-chromosome associations were detected and Xlinked markers explained very little BD heritability. The results add to a growing list of common autosomal variants involved in BD and illustrate the power of comparing well-characterized cases to an excess of controls in GWAS.
Original language | English |
---|---|
Pages (from-to) | 3383-3394 |
Number of pages | 12 |
Journal | Human molecular genetics |
Volume | 25 |
Issue number | 15 |
DOIs | |
State | Published - Aug 1 2016 |
Fingerprint
Dive into the research topics of 'Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Human molecular genetics, Vol. 25, No. 15, 01.08.2016, p. 3383-3394.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder
AU - Hou, Liping
AU - Bergen, Sarah E.
AU - Akula, Nirmala
AU - Song, Jie
AU - Hultman, Christina M.
AU - Landén, Mikael
AU - Adli, Mazda
AU - Alda, Martin
AU - Ardau, Raffaella
AU - Arias, Barbara
AU - Aubry, Jean Michel
AU - Backlund, Lena
AU - Badner, Judith A.
AU - Barrett, Thomas B.
AU - Bauer, Michael
AU - Baune, Bernhard T.
AU - Bellivier, Frank
AU - Benabarre, Antonio
AU - Bengesser, Susanne
AU - Berrettini, Wade H.
AU - Bhattacharjee, Abesh Kumar
AU - Biernacka, Joanna M.
AU - Birner, Armin
AU - Bloss, Cinnamon S.
AU - Brichant-Petitjean, Clara
AU - Bui, Elise T.
AU - Byerley, William
AU - Cervantes, Pablo
AU - Chillotti, Caterina
AU - Cichon, Sven
AU - Colom, Francesc
AU - Coryell, William
AU - Craig, David W.
AU - Cruceanu, Cristiana
AU - Czerski, Piotr M.
AU - Davis, Tony
AU - Dayer, Alexandre
AU - Degenhardt, Franziska
AU - Del Zompo, Maria
AU - DePaulo, J. Raymond
AU - Edenberg, Howard J.
AU - Étain, Bruno
AU - Falkai, Peter
AU - Foroud, Tatiana
AU - Forstner, Andreas J.
AU - Frisén, Louise
AU - Frye, Mark A.
AU - Fullerton, Janice M.
AU - Gard, Sébastien
AU - Garnham, Julie S.
AU - Gershon, Elliot S.
AU - Goes, Fernando S.
AU - Greenwood, Tiffany A.
AU - Grigoroiu-Serbanescu, Maria
AU - Hauser, Joanna
AU - Heilbronner, Urs
AU - Heilmann-Heimbach, Stefanie
AU - Herms, Stefan
AU - Hipolito, Maria
AU - Hitturlingappa, Shashi
AU - Hoffmann, Per
AU - Hofmann, Andrea
AU - Jamain, Stephane
AU - Jiménez, Esther
AU - Kahn, Jean Pierre
AU - Kassem, Layla
AU - Kelsoe, John R.
AU - Kittel-Schneider, Sarah
AU - Kliwicki, Sebastian
AU - Koller, Daniel L.
AU - König, Barbara
AU - Lackner, Nina
AU - Laje, Gonzalo
AU - Lang, Maren
AU - Lavebratt, Catharina
AU - Lawson, William B.
AU - Leboyer, Marion
AU - Leckband, Susan G.
AU - Liu, Chunyu
AU - Maaser, Anna
AU - Mahon, Pamela B.
AU - Maier, Wolfgang
AU - Maj, Mario
AU - Manchia, Mirko
AU - Martinsson, Lina
AU - McCarthy, Michael J.
AU - McElroy, Susan L.
AU - McInnis, Melvin G.
AU - McKinney, Rebecca
AU - Mitchell, Philip B.
AU - Mitjans, Marina
AU - Mondimore, Francis M.
AU - Monteleone, Palmiero
AU - Mühleisen, Thomas W.
AU - Nievergelt, Caroline M.
AU - Nöthen, Markus M.
AU - Novák, Tomas
AU - Nurnberger, John I.
AU - Nwulia, Evaristus A.
AU - Ösby, Urban
AU - Pfennig, Andrea
AU - Potash, James B.
AU - Propping, Peter
AU - Reif, Andreas
AU - Reininghaus, Eva
AU - Rice, John
AU - Rietschel, Marcella
AU - Rouleau, Guy A.
AU - Rybakowski, Janusz K.
AU - Schalling, Martin
AU - Scheftner, William A.
AU - Schofield, Peter R.
AU - Schork, Nicholas J.
AU - Schulze, Thomas G.
AU - Schumacher, Johannes
AU - Schweizer, Barbara W.
AU - Severino, Giovanni
AU - Shekhtman, Tatyana
AU - Shilling, Paul D.
AU - Simhandl, Christian
AU - Slaney, Claire M.
AU - Smith, Erin N.
AU - Squassina, Alessio
AU - Stamm, Thomas
AU - Stopkova, Pavla
AU - Streit, Fabian
AU - Strohmaier, Jana
AU - Szelinger, Szabolcs
AU - Tighe, Sarah K.
AU - Tortorella, Alfonso
AU - Turecki, Gustavo
AU - Vieta, Eduard
AU - Volkert, Julia
AU - Witt, Stephanie H.
AU - Wright, Adam
AU - Zandi, Peter P.
AU - Zhang, Peng
AU - Zollner, Sebastian
AU - McMahon, Francis J.
N1 - Funding Information: The Australian cohort collection was supported by the Australian National Health and Medical Research Council (NHMRC) Program Grants 510135 (PBM) and 1037196 (PBM & PRS); and Project Grants 1063960 (JMF & PRS) and 1066177 (JMF). The Swiss samples were funded by the Swiss National Science Foundation (grant number 32003B_125469 and NCCR Synapsy, Jean-Michel Aubry and Alexandre Dayer). Most importantly, we thank the individuals and families who have participated in and contributed time and data to these studies. Funding Information: This work was supported by the National Institute of Mental Health (NIMH) Intramural Research Program (ZIA-MH00284311; NCT00001174) and a NARSAD Young Investigator Award to L.H. Funding Information: The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health. Additional funds were provided by the NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. Donors were enrolled at Biospecimen Source Sites funded by NCI\SAIC-Frederick, Inc. (SAIC-F) subcontracts to the National Disease Research Interchange (10XS170), Roswell Park Cancer Institute (10XS171), and Science Care, Inc. (X10S172). The Laboratory, Data Analysis, and Coordinating Center (LDACC) was funded through a contract (HHSN268201000029C) to The Broad Institute, Inc. Biorepository operations were funded through an SAIC-F subcontract to Van Andel Institute (10ST1035). Additional data repository and project management were provided by SAIC-F (HHSN261200800001E). The Brain Bank was supported by a supplement to the University of Miami grants DA006227 & DA033684 and to contract N01MH000028. Statistical Methods development grants were made to the University of Geneva (MH090941 & MH101814), the University of Chicago (MH090951, MH090937, MH101820, MH101825), the University of North Carolina - Chapel Hill (MH090936 & MH101819), Harvard University (MH090948), Stanford University (MH101782), Washington University St Louis (MH101810), and the University of Pennsylvania (MH101822). The data used for the analyses described in this manuscript were obtained from the GTEx Portal on 10/12/2015. Funding Information: The Swedish samples were funded by the Stanley Center for Psychiatric Research, Broad Institute from a grant from Stanley Medical Research Institute, the Swedish Research Council (K2014-62X-21445-05-3, K2012-63X-21445-03-2, K2014-62X-14647-12-51 and K2010-61P-21568-01-4), the Söderström-Königska Foundation (SLS-472751), the Swedish foundation for Strategic Research (KF10-0039), and the China Scholarship Council. We would like to thank all of the participants who have kindly given their time and DNA to participate in our research, the Swedish quality register for bipolar disorders (Bipola€R), and data collectors at the Department of Medical Epidemiology and Biostatistics (MEB) at Karolinska Institutet for help with recruitment of participants. Funding Information: M.M.N. is a member of the DFG-funded Excellence-Cluster ImmunoSensation. M.M.N. also received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. The study was supported by the German Research Foundation (DFG; grant ConLiGen RI 908/7-1; grant SFB 636 Z4; grant FOR2107, RI 908/11-1 to M.R., WI 3439/3-1 to S.H.W., NO 246/10-1 to M.M.N.). Funding Information: NIMH Study 19 – Data and biomaterials were collected for the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), a multi-center, longitudinal (5-8 year) project selected from responses to RFP #NIMH-98-DS-0001, ‘Treatment for Bipolar Disorder’. The project was led by Gary Sachs, M.D., and coordinated by Massachusetts General Hospital in Boston, MA. The NIMH grant number was 2N01MH080001-001. Funding Information: The ConLiGen project was in part funded by the Deutsche Forschungsgemeinschaft (DFG; grant no. RI 908/7-1) and the Intramural Research Program of the National Institute of Mental Health (ZIA-MH00284311; NCT00001174). The Romanian sample included in the ConLiGen project was also funded by UEFISCDI, Romania (grant no. 89/2012 awarded to Maria Grigoroiu-Serbanescu, PhD) and BMBF, Germany, grant no. 01GS08144 awarded to M. M. Nöthen and S. Cichon). The Canadian sample has been part of a study funded by the Canadian Institutes of Health Research (grant 64410 to MA). The collection of the Barcelona sample was supported by the Centro de Investigación en Red de Salud Mental (CIBERSAM), IDIBAPS (grant numbers PI080247, PI1200906, PI12/00018) and Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement (2014SGR1636 and 2014SGR398). Funding Information: Genotyping was funded in part by the German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders), under the auspices of the e:Med Programme (grant 01ZX1314G to awarded to Thomas G. Schulze and Marcella Rietschel, grant 01ZX1314A to Sven Cichon and Markus M. Nöthen). Publisher Copyright: © The Author 2016. Published by Oxford University Press. All rights reserved.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Bipolar disorder (BD) is a genetically complex mental illness characterized by severe oscillations of mood and behaviour. Genome-wide association studies (GWAS) have identified several risk loci that together account for a small portion of the heritability. To identify additional risk loci, we performed a two-stage meta-analysis of > 9 million genetic variants in 9,784 bipolar disorder patients and 30,471 controls, the largest GWAS of BD to date. In this study, to increase power we used ~2,000 lithium-treated cases with a long-term diagnosis of BD from the Consortium on Lithium Genetics, excess controls, and analytic methods optimized for markers on the X-chromosome. In addition to four known loci, results revealed genome-wide significant associations at two novel loci: an intergenic region on 9p21.3 (rs12553324, P= 5.87×10-9; odds ratio (OR)=1.12) and markers within ERBB2 (rs2517959, P= 4.53×10-9; OR=1.13). No significant X-chromosome associations were detected and Xlinked markers explained very little BD heritability. The results add to a growing list of common autosomal variants involved in BD and illustrate the power of comparing well-characterized cases to an excess of controls in GWAS.
AB - Bipolar disorder (BD) is a genetically complex mental illness characterized by severe oscillations of mood and behaviour. Genome-wide association studies (GWAS) have identified several risk loci that together account for a small portion of the heritability. To identify additional risk loci, we performed a two-stage meta-analysis of > 9 million genetic variants in 9,784 bipolar disorder patients and 30,471 controls, the largest GWAS of BD to date. In this study, to increase power we used ~2,000 lithium-treated cases with a long-term diagnosis of BD from the Consortium on Lithium Genetics, excess controls, and analytic methods optimized for markers on the X-chromosome. In addition to four known loci, results revealed genome-wide significant associations at two novel loci: an intergenic region on 9p21.3 (rs12553324, P= 5.87×10-9; odds ratio (OR)=1.12) and markers within ERBB2 (rs2517959, P= 4.53×10-9; OR=1.13). No significant X-chromosome associations were detected and Xlinked markers explained very little BD heritability. The results add to a growing list of common autosomal variants involved in BD and illustrate the power of comparing well-characterized cases to an excess of controls in GWAS.
UR - http://www.scopus.com/inward/record.url?scp=85014343531&partnerID=8YFLogxK
U2 - 10.1093/hmg/ddw181
DO - 10.1093/hmg/ddw181
M3 - Article
C2 - 27329760
AN - SCOPUS:85014343531
SN - 0964-6906
VL - 25
SP - 3383
EP - 3394
JO - Human molecular genetics
JF - Human molecular genetics
IS - 15
ER -